OncoCyte Corporation

MUN:7OC0 Stock Report

Market Cap: €38.2m

OncoCyte Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

MUN:7OC0 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
26 Dec 24Buy€25,301Andrew ArnoIndividual12,500€2.02
26 Dec 24Buy€184,518Patrick SmithIndividual90,219€2.05
05 Dec 24Buy€43,331Andrea JamesIndividual20,000€2.17
02 Oct 24Buy€3,511,184Broadwood Capital, Inc.Company1,315,339€2.67
02 Oct 24Buy€90,550Andrea JamesIndividual33,670€2.69
11 Apr 24Buy€93,369Andrew ArnoIndividual33,898€2.75
11 Apr 24Buy€9,337Joshua RiggsIndividual3,390€2.75
11 Apr 24Buy€6,589,763Broadwood Capital, Inc.Company2,420,000€2.72

Insider Trading Volume

Insider Buying: 7OC0 insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 7OC0?
Owner TypeNumber of SharesOwnership Percentage
Private Companies00%
Institutions1,221,4377.26%
Public Companies1,510,9448.97%
Individual Insiders1,939,55511.5%
General Public4,821,73128.6%
Hedge Funds7,341,58043.6%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 103.8%.

Top Shareholders

Top 25 shareholders own 71.35% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
37.1%
Broadwood Capital, Inc.
6,244,405€14.2m26.7%1.14%
10.5%
Patrick Smith
1,773,903€4.0m0%no data
8.97%
Bio-Rad Laboratories, Inc.
1,510,944€3.4m25.9%no data
6.52%
AWM Investment Company Inc
1,097,175€2.5m0%0.3%
2.94%
Pura Vida Investments, LLC
495,345€1.1m0%2.14%
1.46%
The Vanguard Group, Inc.
245,388€556.7k0.37%no data
0.62%
Geode Capital Management, LLC
103,980€235.9k12.2%no data
0.58%
Andrew Arno
97,162€220.4k14.8%no data
0.47%
BlackRock, Inc.
79,833€181.1k9.62%no data
0.43%
Morgan Stanley, Investment Banking and Brokerage Investments
72,289€164.0k-8.14%no data
0.41%
Lockheed Martin Corporation Master Retirement Trust
69,072€156.7k0%100.0%
0.35%
Defender Capital LLC
59,353€134.7k7.48%0.04%
0.32%
Andrea James
53,670€121.8k0%no data
0.25%
FNY Investment Advisers, LLC
42,896€97.3k81.4%0.05%
0.12%
State Street Global Advisors, Inc.
19,554€44.4k0%no data
0.1%
Northern Trust Global Investments
17,346€39.4k0%no data
0.059%
Abaris Investment Management AG
10,000€22.7k0%0.03%
0.03%
Ekkehard Schutz
5,085€11.5k1,520%no data
0.027%
Andrew Last
4,509€10.2k79.7%no data
0.021%
Joshua Riggs
3,505€8.0k0%no data
0.01%
Lord, Abbett & Co. LLC
1,675€3.8k0%no data
0.0093%
Louis Silverman
1,564€3.5k0%no data
0.0086%
Tower Research Capital Europe Limited
1,446€3.3k-52.9%no data
0.0064%
Advisor Group Holdings, Inc., Asset Management Arm
1,080€2.5k0%no data
0.005%
UBS Asset Management AG
835€1.9k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/03 10:44
End of Day Share Price 2024/10/31 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

OncoCyte Corporation is covered by 8 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mark MassaroBTIG
Paul KnightJanney Montgomery Scott LLC
null nullKeyBanc Capital Markets Inc.